Evidence map›Paper›PMID 42443231›Full record

ArticleScientific reports2026

StyleGAN3-T: an alias-free generative framework for synthetic plant disease image augmentation and recognition.

Shahin Aghabalayev, Ahmed N Abdalla, Tao Hai, Yao Liu, Ancheng Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shahin AghabalayevFaculty of Electronic Information Engineering, Huaiyin Institute of Technology, Huai'an, 2230022, China.
Ahmed N AbdallaFaculty of Electronic Information Engineering, Huaiyin Institute of Technology, Huai'an, 2230022, China. dramaidecn@gmail.com.
Tao HaiArtificial Intelligence Research Center (AIRC), Ajman University, P.O.Box:346, Ajman, United Arab Emirates. t.hai@ajman.ac.ae.
Yao LiuFaculty of Electronic Information Engineering, Huaiyin Institute of Technology, Huai'an, 2230022, China.
Ancheng WangFaculty of Electronic Information Engineering, Huaiyin Institute of Technology, Huai'an, 2230022, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To address this challenge, we propose StyleGAN3-T, the translation-equivariant alias-free variant of StyleGAN3, as a generative framework for producing high-fidelity synthetic plant disease images, integrated with a hybrid Swin Transformer-ResNet50 classifier for precise recognition. Accurate detection of plant leaf diseases is essential for sustainable agriculture and early intervention. However, deep learning models often struggle with small, imbalanced datasets that limit generalization and robustness. To address this challenge, we propose StyleGAN3-T, a novel alias-free generative framework for producing high-fidelity synthetic plant disease images, integrated with a hybrid Swin Transformer-ResNet50 classifier for precise recognition. The proposed approach ensures translation-equivariant, artifact-free image synthesis and enhanced feature diversity. A balanced dataset of 18,000 images was developed by combining real and StyleGAN3-T-generated samples. In pooled GAN benchmarking, StyleGAN2-ADA achieved the strongest generative-quality metrics, whereas StyleGAN3-T was selected as the preferred augmentation model because its alias-free synthesis and spatial consistency yielded superior downstream classification performance in the proposed pipeline.

Indexed as

Image Processing, Computer-AssistedPlant DiseasesConvolutional Neural NetworksDeep LearningGenerative Adversarial NetworksGenerative Artificial IntelligenceGrapevine diseaseImage augmentationResNet50StyleGAN3-TSynthetic data

Identifiers

PMID42443231
PMCPMC13365611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.